Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Julphar
Boehringer Ingelheim
Fuji
Accenture
Chinese Patent Office
Deloitte
Johnson and Johnson

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,127,425

« Back to Dashboard

Which drugs does patent 6,127,425 protect, and when does it expire?


Patent 6,127,425 protects SOLTAMOX and is included in one NDA.

This patent has six patent family members in seven countries.

Summary for Patent: 6,127,425

Title: Oral liquid medicine solution
Abstract:Found is a pharmaceutical preparation which provides Tamoxifen Citrate in a liquid dosage form, viz. as an oral solution. The finding is based on a solvent comprising the following components: (a) of from 10% to 20% by weight of ethanol, (b) of from 10% to 60% by weight of a glycol; and (c) water, optionally containing additives, in a volume percentage adding up to 100% by volume. A preferred additive is sorbitol.
Inventor(s): Tully; Roger Edward (Ilkley, GB)
Assignee: Akzo Nobel N.V. (Arnhem, NL)
Application Number:09/106,172
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Delivery; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Midatech Pharma UsSOLTAMOXtamoxifen citrateSOLUTION;ORAL021807-001Oct 29, 2005RXNoNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,127,425

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
97201964Jun 27, 1997

International Patent Family for Patent: 6,127,425

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria214269► Subscribe
Germany69804169► Subscribe
Denmark0893121► Subscribe
European Patent Office0893121► Subscribe
Spain2174388► Subscribe
JapanH1171269► Subscribe
Portugal893121► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
US Army
Cantor Fitzgerald
Novartis
Covington
Merck
Johnson and Johnson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot